MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer (Q38779984)

6 September 2017

title

MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer (English)

1 reference

6 September 2017

1 reference

Guopei Zheng

1 reference

6 September 2017

Nan Li

1 reference

6 September 2017

Xiaoting Jia

1 reference

6 September 2017

Cong Peng

1 reference

6 September 2017

Liyun Luo

1 reference

6 September 2017

Yingen Deng

1 reference

6 September 2017

Jiang Yin

1 reference

6 September 2017

Ying Song

1 reference

6 September 2017

Hao Liu

1 reference

6 September 2017

Minying Lu

1 reference

6 September 2017

Zhijie Zhang

1 reference

6 September 2017

Yixue Gu

1 reference

6 September 2017

Zhimin He

1 reference

6 September 2017

publication date

8 April 2016

1 reference

Journal of Molecular Medicine

6 September 2017

published in

1 reference

6 September 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Implication of microRNAs in drug resistance for designing novel cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Many roads to maturity: microRNA biogenesis pathways and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

MicroRNAs and cancer: short RNAs go a long way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Identification of carbonic anhydrase 9 as a contributor to pingyangmycin‐induced drug resistance in human tongue cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

MYCN oncoprotein targets and their therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Reflecting on 25 years with MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

21 January 2018

Neuroblastoma and MYCN

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1417-0

[Influence of induction chemotherapy on long-time effect of patients with tongue squamous cell carcinoma]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27055844

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27055844

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00109-016-1417-0

0 references

Dimensions Publication ID

1016217191

0 references

1 reference